Estimation of lifetime benefits from the optimization of secondary prevention in patients with established atherosclerotic cardiovascular disease - Top-Institutions - MDSpire

Estimation of lifetime benefits from the optimization of secondary prevention in patients with established atherosclerotic cardiovascular disease

  • By

  • Jennifer L Gill

  • Aurelio Miracolo

  • Konstantina Politopoulou

  • Efstratios A Apostolou

  • Sahan A Jayawardana

  • Alex W Carter

  • Panos G Kanavos

  • January 13, 2026

  • 0 min

Share

Top Institutions in Cardiology

Brief introduction explaining scope and methodology.

  • #1

    Cleveland Clinic
    Cleveland Clinic

    Cleveland, OH

    Key Differentiators

    • Cardiology
    • Preventive Cardiology
    • Cardiovascular Epidemiology

  • #2

    Johns Hopkins University School of Medicine
    Johns Hopkins University School of Medicine

    Baltimore, MD

    Key Differentiators

    • Cardiology
    • Cardiovascular Epidemiology
    • Preventive Medicine

  • #3

    European Society of Cardiology (ESC) - affiliated research centers
    European Society of Cardiology (ESC) - affiliated research centers

    Various, Europe

    Key Differentiators

    • Cardiology
    • Preventive Cardiology
    • Health Policy

  • #4

    Massachusetts General Hospital
    Massachusetts General Hospital

    Boston, MA

    Key Differentiators

    • Cardiology
    • Preventive Cardiology
    • Clinical Research

  • #5

    Imperial College London
    Imperial College London

    London, UK

    Key Differentiators

    • Cardiology
    • Public Health
    • Cardiovascular Epidemiology

Original Source(s)

Estimation of lifetime benefits from the optimization of secondary prevention in patients with established atherosclerotic cardiovascular disease

  • by Jennifer L Gill, Aurelio Miracolo, Konstantina Politopoulou, Efstratios A Apostolou, Sahan A Jayawardana, Alex W Carter, Panos G Kanavos

  • January 13, 2026

Related Content

Non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio is associated with cardiovascular outcomes after percutaneous coronary intervention in patients with type 2 diabetes

What RVO May Reveal About Systemic Health

TriNetX data presented at Retina World Congress linked BRVO and CRVO with increased risks of stroke, myocardial infarction, and carotid disease.

Serum uric acid levels and cardiorenal complication prevalence in hypertensive patients before and after the COVID-19 pandemic: a retrospective cross-sectional study from a tertiary traditional Chinese medicine hospital